Athersys, Inc.: Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in January
Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) for critical care indications, announced today their participation in two January conferences, Advanced